|
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910760288503321 |
|
|
Autore |
Pal Dilipkumar |
|
|
Titolo |
Anti-Viral Metabolites from Medicinal Plants [[electronic resource] /] / edited by Dilipkumar Pal |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2024 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2024.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (1134 pages) |
|
|
|
|
|
|
Collana |
|
Reference Series in Phytochemistry, , 2511-8358 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Natural products |
Botany |
Botanical chemistry |
Pharmaceutical chemistry |
Natural Products |
Plant Science |
Plant Biochemistry |
Pharmaceutics |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Chapter 1 Introduction of medicinal plants as source of anti-viral metabolite(s), effects on health and general adverse effects -- Chapter 2:General plants showing anti-viral activity giving emphasis on CDRI’s biological screening programme -- Chapter 3: Classification of medicinal plants having anti-viral activity as per (i) family and (ii) types of viral infections -- Chapter 4: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 1 infections -- Chapter 5: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 2 infections -- Chapter 6: Role of various medicinal plants against in HIV infection in human with possible mechanism of action and functions of secondary metabolites -- Chapter 7: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of different medicinal plants against Hepatitis B infections -- |
|
|
|
|
|
|
|
|
|
|
|
Chapter 8: Antiviral effects of different medicinal plants against Hepatitis C (HCV) infection: Role of phytochemicals -- Chapter 9: Medicinal plants in controlling Pox virus affections:Ethnopharmacology, chemistry, clinical, preclinical studies and future perspectives -- Chapter 10: Role of medicinal plants in prevention and treatment of Respiratory viral infections -- Chapter 11: Assessment of effectiveness of herbal drugs in prevention and treatment against Gastrointestinal viral diseases -- Chapter 12: Antiviral potential of medicinal plants in treatment of diseases caused by Influenza virus A: Role of secondary metabolites, clinical and preclinical studies and future perspectives -- Chapter 13: Role of medicinal plants in treatment of diseases caused by Influenza virus B and Parainfluenza virus type 3 -- Chapter 14: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on the uses of herbal drugs against Polio Infections -- Chapter 15: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of medicinal plants against SARS-CoV/Corona virus infections -- Chapter 16: Medicinal plants in controlling and treatment of diseases caused by Viral Haemorrhagic Septicaemia Virus (VHSV) -- Chapter 17:Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against vesicular stomatitis virus (VSV) infections -- Chapter 18: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of various medicinal plants against Human Adenovirus Type 1 infections -- Chapter 19: Medicinal plants used by traditional medical practitioner in controlling and treatment of Cutaneous viral diseases: Ethnopharmacology, chemistry, Clinical and preclinical studies -- Chapter 20: Herbal drugs and medicinal plants in controlling and treatment for the diseases caused by Dengue virus (DEN-1 & 2): Ethnopharmacology, chemistry, clinical and preclinical studies -- Chapter 21: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of natural medicinal plants against Neurological viral diseases -- Chapter 22: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on traditional crude drugs against Encephalitis infection -- Chapter 23: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use natural plants in the treatment of Renal syndrome caused by viruses -- Chapter 24: Natural products in controlling and treatment of cancers and genital warts caused by different viruses -- Chapter 25: Role of traditional plants in controlling and treatment of fever, joint pain and pogosta diseases caused by viruses -- Chapter 26: Natural medicinal plants used in in controlling and treatment of diseases caused by Coxsackie and Coxsackie virus B3 with possible mechanism of action and role of phytochemicals -- Chapter 27: Phytochemical, clinical and preclinical studies focusing on use Indigenous plants against Cytomegalovirus, Cytomegalovirus B1 and Epstein-Barr virus infection: Prevalence and impact on patients with haematological diseases -- Chapter 28: Flavonoids: promising natural compounds against viral infections: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives -- Chapter 29: Coumarins: emerging antiviral compounds from natural origin: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives -- Chapter 30: Antiviral potential of Curcumins: Ethnopharmacology, chemistry, clinical studies focusing on mechanism of action and future perspectives. |
|
|
|
|
|
|
Sommario/riassunto |
|
This reference work covers general concepts of anti-viral metabolites, classifications, ethnopharmacology, chemistry, clinical and preclinical studies focusing on different medicinal plants against various types of viral infections. Various plants have been used in medicine since |
|
|
|
|
|
|
|
|
|
|
ancient times and are known for their strong therapeutic effects. The book will describe potential antiviral properties of medicinal plants against a diverse group of viruses, and provide an insight to the potential plants possess for broad-spectrum antiviral effects against emerging viral infections. The book aims to target a broad audience including virologists, molecular biologist, microbiologist and scientists working with natural products as well as researchers, students, healthcare experts involved in pharmaceutical and medical field. |
|
|
|
|
|
| |